The Effect of Virtual Reality on Pain and Anxiety During Blood Collection in Adults
1 other identifier
interventional
76
1 country
1
Brief Summary
In hospitals, venous blood sampling as the first step in diagnosis and planning of medical treatment is among the most basic and common procedures all over the world. Before the diagnosis and treatment of acute or chronic health problems, venous blood is requested from the doctors and the blood sample is collected by the nurses. Patients experience anxiety for reasons such as the fear of experiencing pain during the blood donation process, fear of seeing blood, and fear that blood-borne diseases will pass. Studies in the literature have generally evaluated the effects on pain and fear by using virtual reality with different techniques in pediatric patients during blood collection, and the relevant research has been reached in adult patients. The aim of this research is to determine the effect of virtual reality on pain and anxiety during blood collection of patients who applied to the blood collection unit of a university hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2022
CompletedFirst Submitted
Initial submission to the registry
April 29, 2022
CompletedFirst Posted
Study publicly available on registry
May 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2022
CompletedNovember 27, 2023
November 1, 2023
6 months
April 29, 2022
November 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
State Anxiety Scale mean score
State Anxiety Scale mean scores of adult patients in the intervention and control groups will be compared before and after the intervention. A minimum of 20 and a maximum of 80 points can be obtained from the scale. If the scale score approaches 80, it indicates high anxiety.
10 minute
Visual Analog Scale mean score
Mean Visual Analog Scale scores for adult patients of the intervention and control groups will be compared at the time of intervention.The minimum score to be taken from the scale is zero, the maximum score is 10. It shows that the severity of pain increases as the Visual Analog Scale score approaches 10 during blood collection.
2 minute (during the process)
Study Arms (2)
Experimental group
EXPERIMENTALPatients in the experimental group will be informed about the using virtual reality glasses during the taking blood. During this process, their anxiety and pain will be assesed. Patients in the study group will be evaluated 2 times, before the intervention and after the intervention, through data collection tools.
Control group
NO INTERVENTIONThe control group will receive standard procedure without any intervention
Interventions
The patient, whose blood will be drawn, will be asked to wear virtual reality glasses after sitting in the blood collection chair. One minute before the start of the blood collection process, "Nature Hiking" will be watched from the virtual reality. Meanwhile, the researcher will complete the preparations for blood collection and will start the blood collection process. It is thought that the blood collection process takes 2-3 minutes on average. During this period, virtual reality will be applied. While blood is being drawn from the patient, the researcher will assess the patient's level of pain with the VAS during the procedure. After the blood draw is completed, the virtual reality glasses will be removed. Then, the patient will be taken to the waiting area and the state anxiety scale will be applied.
Eligibility Criteria
You may qualify if:
- Voluntarily agreed to participate in the research.
- Being 18 years or older
- Being able to read and write Turkish
- No vision and hearing problems
- Not using glasses
- Absence of any psychiatric, cognitive or neurological disease
You may not qualify if:
- Patients with visual or hearing impairment
- Patients whose blood cannot be drawn in once
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Necmettin Erbakan University Medical Faculty Hospital
Konya, 42020, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Serap SAYAR, PhD
KTO Karatay University
- PRINCIPAL INVESTIGATOR
Magbul Ahmet Çoban, MScN student
Necmettin Erbakan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Single Blinded
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, PhD
Study Record Dates
First Submitted
April 29, 2022
First Posted
May 9, 2022
Study Start
March 10, 2022
Primary Completion
September 12, 2022
Study Completion
September 12, 2022
Last Updated
November 27, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share
The researcher at Necmettin Erbakan University will collect the data